Search
Find a recruiting study
7,106 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Nov 1, 2026). No sign-up needed.
Most recently updated studies · page 108 of 297
- RecruitingPhase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
Takeda
- Location
- Arkansas City, AR + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Global Trial in APG2575 for Patients With CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Tuscon, AZ + 10 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingEarly Phase 1
VTP-1000 in Adults With Celiac Disease
Barinthus Biotherapeutics
- Location
- Los Angeles, CA + 15 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
AbbVie
- Location
- Birmingham, AL + 14 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney…
Alexion Pharmaceuticals, Inc.
- Location
- Phoenix, AZ + 28 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Alexion Pharmaceuticals, Inc.
- Location
- Loma Linda, CA + 4 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis
Airiver Medical, Inc.
- Location
- Baltimore, MD
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
Efficacy and Safety Study of TPX-115 on Partial-thickness Rotator Cuff Tear
Tego Science, Inc.
- Location
- La Mesa, CA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
AbbVie
- Location
- Huntsville, AL + 46 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds
NuScience Medical Biologics, LLC
- Location
- Denham Springs, LA + 9 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
NuScience Medical Biologics, LLC
- Location
- Alexandria, LA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
BioMarin Pharmaceutical
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingPhase 1
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
Corxel Pharmaceuticals
- Location
- Las Vegas, NV + 1 other US site
- Eligibility basics
- Ages 18–55 · Women only
- RecruitingPhase 2
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Syndax Pharmaceuticals
- Location
- Birmingham, AL + 12 other US sites
- Eligibility basics
- Ages 2+
- Recruiting
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
Avvio Medical
- Location
- Phoenix, AZ + 11 other US sites
- Eligibility basics
- Ages 21+
- Recruiting
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
ONWARD Medical, Inc.
- Location
- Little Rock, AR + 11 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
Incyte Corporation
- Location
- Miami Lakes, FL + 1 other US site
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2/Phase 3
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Urovant Sciences GmbH
- Location
- Little Rock, AR + 6 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
Testing of GripTract-GI Endoscopic Tissue Manipulator for Use During Complex Endoscopic Polypectomies in the Colon
Actuated Medical, Inc.
- Location
- Cleveland, OH
- Eligibility basics
- Ages 21+
- RecruitingPhase 2
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Oneness Biotech Co., Ltd.
- Location
- Fountain Valley, CA + 5 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Radiation Free Study
Philips Clinical & Medical Affairs Global
- Location
- Birmingham, AL + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
ModernaTX, Inc.
- Location
- Farmington Hills, MI + 5 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 2
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
AbbVie
- Location
- Dothan, AL + 32 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
Sano Chemicals Inc
- Location
- Birmingham, AL
- Eligibility basics
- Ages 18–65 · Women only
Data source: daily sync of the ClinicalTrials.gov API. How we list studies